🏥 VAERS Vaccine Data Browser

🔒 Privacy & Data Disclaimer

About This Site

This is a public data browser for the Vaccine Adverse Event Reporting System (VAERS). By using this site, you acknowledge and agree to the following:

Data Source & Accuracy

  • Public Data: All data displayed comes from the publicly available VAERS database maintained by the CDC and FDA.
  • No Verification: VAERS accepts all reports without verifying medical accuracy. Reports do not prove causation between vaccines and adverse events.
  • Anyone Can Report: Healthcare providers, patients, family members, and anyone else can submit reports to VAERS.
  • Research Purpose: This data is for transparency, research, and monitoring vaccine safety signals only.

Your Privacy

  • No Personal Data Collection: This site does not collect, store, or track any personal information about visitors.
  • No Cookies: We do not use cookies except for remembering that you've seen this disclaimer (stored locally in your browser).
  • No Analytics: We do not use Google Analytics or any other tracking services.
  • Search Privacy: Your searches and filters are not logged or stored on our servers.
  • Public Data Only: The VAERS data shown here is already public and contains no personally identifiable information.

Medical Disclaimer

  • Not Medical Advice: This tool is for informational purposes only and does not provide medical advice.
  • Consult Healthcare Providers: Always consult qualified healthcare professionals for medical decisions.
  • No Liability: We are not responsible for decisions made based on this data.

Data Interpretation

  • The presence of a report does not mean the vaccine caused the adverse event.
  • Coincidental events are often reported (e.g., a heart attack that happened to occur after vaccination).
  • Serious adverse events must be reported by law, even if unrelated to the vaccine.
  • The database is useful for detecting safety signals that require further investigation.

📖 Help & Search Guide

Column Icons Legend

💀 Death
🏥 Hospitalized
🚑 Emergency Room
♿ Disability
⚠️ Life Threatening

How to Search

💡 Search Tips:
  • Select Year: Choose a specific year OR "All Years" to search across all data
  • All Years requires filters: When searching all years, you must select at least one filter (lot number, vaccine type, outcome, etc.) for performance
  • Lot number tracking: Use "All Years" + Lot Number to track lots across multiple years
  • Combine filters: Use multiple filters together to narrow results (e.g., Age + Vaccine Type + Death)
  • VAERS ID: Search for specific report by ID number
  • Age: Enter exact age (e.g., 25) or decimal (e.g., 0.5 for 6 months)
  • State: Enter 2-letter state code (e.g., CA, NY, TX)
  • Vaccine Type: Search partial names (e.g., "COVID19", "FLU", "HPV")
  • Manufacturer: Search by company (e.g., "PFIZER", "MODERNA")
  • Lot Number: Search specific vaccine lot (works great with "All Years")
  • Symptoms: Search for any symptom keyword (e.g., "fever", "rash")
  • Death/Hospitalized: Filter to only show cases with these outcomes

Understanding the Data

  • Reports are unverified: VAERS accepts all reports without medical verification
  • Not proof of causation: A report does not mean the vaccine caused the event
  • Anyone can report: Healthcare providers, patients, and family members can submit reports
  • Multiple vaccines: One report may list multiple vaccines given at the same time
  • Blank fields: Not all fields are required, so some data may be missing

Using the Table

  • Sort columns: Click column headers (ID, Age, Sex, Date, Died) to sort
  • Expand text: Click "More" to see full narrative or symptom text
  • Navigate pages: Use pagination controls at top and bottom of table
  • Export results: Click "📥 Export CSV" to download filtered data (max 10,000 records)

💡 Frequently Asked Questions (FAQ)

What is this site?

🏥 VAERS Vaccine Data Browser is an independent, third-party data browser for publicly available VAERS (Vaccine Adverse Event Reporting System) data.

Important: This site is NOT affiliated with, endorsed by, or operated by the CDC, FDA, or any government agency. We are an independent service that makes public VAERS data easier to search and analyze.

What is VAERS?

VAERS (Vaccine Adverse Event Reporting System) is a national early warning system established in 1990 to detect possible safety problems with vaccines. It's co-managed by the CDC (Centers for Disease Control and Prevention) and FDA (Food and Drug Administration).

VAERS accepts and analyzes reports of adverse events (possible side effects) after a person has received a vaccination.

Official VAERS website: vaers.hhs.gov

Is this data HIPAA compliant?

Yes, absolutely. All VAERS data displayed here is:

  • Publicly available - Published by the CDC/FDA on their official website
  • De-identified - Contains no personally identifiable information (names, addresses, contact info removed)
  • Legally accessible - Available to researchers, media, and the general public under FOIA (Freedom of Information Act)
  • Not protected health information - Once de-identified and published by the government, it's no longer covered by HIPAA restrictions

This site displays the same public data available at vaers.hhs.gov/data.

Why does this site exist?

We believe in transparency and public access to health data. While the CDC/FDA provide VAERS data, their official site:

  • Is difficult to search and filter
  • Requires downloading large CSV files and technical knowledge
  • Is not user-friendly for the average person

This independent site makes the same publicly available data easier to search, filter, and understand for researchers, journalists, healthcare workers, and concerned citizens.

Where does the data come from?

All data is downloaded directly from the official CDC/FDA VAERS website at vaers.hhs.gov/data.

The data is:

  • Publicly released by the CDC/FDA every week
  • Available as downloadable CSV files
  • Imported into this site's database for easier searching
  • Displayed exactly as provided (no modifications or filtering)

This site does not collect, modify, or add to the official VAERS data.

My vaccine lot number matches one with deaths/serious events - should I be worried?

Important context:

  • VAERS reports do NOT prove causation - A report means an event occurred after vaccination, but doesn't mean the vaccine caused it
  • Anyone can report - Reports are not verified for medical accuracy before being published
  • Coincidences happen - When millions of people get vaccinated, some will experience unrelated medical events afterward
  • Large lot numbers - Popular vaccines may have hundreds of thousands of doses from one lot number
  • More vaccinations = more reports - Lots used widely will naturally have more reports

What to do:

  • Don't panic - VAERS data requires expert analysis to interpret
  • Talk to your doctor if you have concerns
  • Check official CDC/FDA safety communications for genuine safety signals
  • Remember: billions of vaccine doses have been safely administered

Can I trust VAERS data?

VAERS is valuable but has limitations:

Strengths:

  • ✅ Early warning system for potential safety signals
  • ✅ Open and transparent - publicly accessible
  • ✅ Accepts all reports regardless of likelihood of causation
  • ✅ Monitored by CDC/FDA experts who investigate concerning patterns

Limitations:

  • ⚠️ Reports are unverified - not investigated before publication
  • ⚠️ Cannot determine if vaccine caused the event
  • ⚠️ Underreporting - not all adverse events are reported
  • ⚠️ Overreporting - coincidental events may be reported
  • ⚠️ Incomplete data - not all fields are required

Bottom line: VAERS is an important tool for safety monitoring, but individual reports should not be used as proof that a vaccine caused harm.

What are "adverse events"?

An adverse event is any undesirable health occurrence that happens after vaccination, including:

  • Common reactions: Sore arm, mild fever, fatigue (usually expected)
  • Serious events: Hospitalization, disability, life-threatening illness, death
  • Coincidental events: Medical conditions that would have occurred anyway

Important: An adverse event doesn't mean the vaccine caused it - only that it occurred after vaccination. Many reported events are coincidental or unrelated.

Why are some lot numbers listed multiple times?

This is normal and expected! A person may receive multiple doses of the same vaccine from the same lot number:

  • COVID vaccines require 2-3 doses
  • HPV, Hepatitis B, and other vaccines have multi-dose schedules
  • Each dose is recorded as a separate entry

Example: Person receives Pfizer COVID dose 1 (lot ABC123) and dose 2 (lot ABC123) - lot ABC123 appears twice in their report.

How often is this data updated?

The CDC/FDA releases new VAERS data every Friday. This site is typically updated:

  • Weekly or bi-weekly for recent data
  • Check the available years to see what data is currently loaded
  • During updates, the site may be in maintenance mode temporarily

Where can I learn more?

⚠️ DISCLAIMER: This data is from the Vaccine Adverse Event Reporting System (VAERS). Reports do not establish causation between vaccines and adverse events. Anyone can submit a report, and reports are not verified. This is raw data for transparency and research purposes only.
34,052
Total Reports (2025)
500
Deaths Reported
1,634
Hospitalizations
30
ER Visits
1,191
Disabilities
570
Life Threatening
🔄 Reset 📥 Export CSV
ID Age Sex State Date ▼ Onset Days Vaccine Manufacturer Lot # Symptoms Narrative 💀 🏥 🚑 ♿ ⚠️
2855831 1.5 F ID 08/27/2025 DTAP
 SANOFI PASTEUR
 3CA55C1
Hypersensitivity, Urticaria Hypersensitivity, Urticaria
Urtica/hives to body from face, trunk, arms, and legs - Allergic reaction Urtica/hives to body from face, trunk, arms, and legs - Allergic reaction
2855832 53 F OR 08/27/2025 PNC20
TDAP
 PFIZER\WYETH
GLAXOSMITHKLINE BIOLOGICALS
 LC5484
XN575
Arthralgia, Injection site pain, Musculoskeletal discomfort; Arthralgia, Injecti... Arthralgia, Injection site pain, Musculoskeletal discomfort; Arthralgia, Injection site pain, Musculoskeletal discomfort More
Patient presents on 8/27/2025 to report muscle soreness at injection site after DOS. Approximately 1... Patient presents on 8/27/2025 to report muscle soreness at injection site after DOS. Approximately 1 week later, muscle pain had resolved but pain in joint was more pronounced. Reports joint discomfort was concurrent w/ muscle pain since injection date. Pt was advised to take 200-400 mg of Ibuprofen nightly and was referred to physical therapy. More
2855839 70 M CA 08/27/2025 COVID19
 UNKNOWN MANUFACTURER
 5683MF012
Arthritis Arthritis
Mild inflammation on his knee after having the Novavax vaccine; This non-serious initial spontaneous... Mild inflammation on his knee after having the Novavax vaccine; This non-serious initial spontaneous report was reported by a consumer or other non-health professional via contact center (No. NOV25-00632) and concerns an elderly Male who experienced "MILD INFLAMMATION ON HIS KNEE AFTER HAVING THE NOVAVAX VACCINE" after receiving COVID-19 Vaccine, Adjuvanted (2023-2024 Formula) on 23-Oct-2023. At the time of the report, the outcome of the event Arthritis was Recovered/Resolved. A few discrepancies were identified in the source document. Patient's age group was reported as "Adult" but was captured as "Elderly" according to the reported date of birth. The Novavax vaccination information reported for the 'Body Site Location' of the product administration was provided as "Left". Left arm was conservatively selected and will be confirmed with the query sent to the consumer.; Sender's Comments: This Male of an unspecified age experienced Arthritis after vaccination with COVID-19 Vaccine, Adjuvanted (2023-2024 Formula). The event Arthritis was reported as non-serious. Based on the spontaneous nature of the report, the causal relationship between COVID-19 Vaccine, Adjuvanted (2023-2024 Formula) and Arthritis is considered Possible. More
2855840 4 M OR 08/27/2025 MMRV
 MERCK & CO. INC.
 Z008219
Extra dose administered Extra dose administered
Additional dose of MMRV given to patient as a new patient 4 year old child at 4 year well child chec... Additional dose of MMRV given to patient as a new patient 4 year old child at 4 year well child check. Patient had already received 2n dose in another state at the age of 3. More
2855841 0.5 F AZ 08/27/2025 DTPPVHBHPB
 MSP VACCINE COMPANY
 U8314AA
Injection site bruising, Injection site mass Injection site bruising, Injection site mass
Lump on thigh. Bruising still apparent after 2 months Lump on thigh. Bruising still apparent after 2 months
2855842 2 M MT 08/27/2025 VARCEL
 MERCK & CO. INC.
 x001000
Expired product administered Expired product administered
Expired vaccine given by accident Expired vaccine given by accident
2855843 60 F CO 08/27/2025 PNC21
 MERCK & CO. INC.
Pain, Pyrexia, Somnolence Pain, Pyrexia, Somnolence
Fever up to 102 achy and sleepy Fever up to 102 achy and sleepy
2855849 21 F WI 08/27/2025 FLU3
HEP
TDAP
 SEQIRUS, INC.
DYNAVAX TECHNOLOGIES CORPORATION
GLAXOSMITHKLINE BIOLOGICALS
 406984
948203
H4K3S
Blood glucose normal, Dizziness, Seizure, Urinary incontinence; Blood glucose no... Blood glucose normal, Dizziness, Seizure, Urinary incontinence; Blood glucose normal, Dizziness, Seizure, Urinary incontinence; Blood glucose normal, Dizziness, Seizure, Urinary incontinence More
Patient stated she had a history of dizziness after vaccines. After vaccines were administered, she... Patient stated she had a history of dizziness after vaccines. After vaccines were administered, she was asked to sit in a chair in our waiting room for observation. When she tried to stand up after waiting approximately 5 minutes she started to feel dizzy, sat back down in chair, had a small seizure and lost bladder control. 911 was called and patient was evaluated by them - her blood pressure, oxygen and glucose were all within normal range. She declined paramedics taking her to the hospital. More
2855850 53 F CA 08/27/2025 PPV
 MERCK & CO. INC.
Unevaluable event Unevaluable event
Patient will have to go the pharmacy to get another dose of pneumovax 23 Patient will have to go the pharmacy to get another dose of pneumovax 23
2855851 16 F AZ 08/27/2025 MNQ
TDAP
 SANOFI PASTEUR
GLAXOSMITHKLINE BIOLOGICALS
 U8194AA
9JT4S
Extra dose administered, No adverse event; Extra dose administered, No adverse e... Extra dose administered, No adverse event; Extra dose administered, No adverse event More
Mom provided vaccination record and according to system, child was due for TDAP and MCV4. It wasn�... Mom provided vaccination record and according to system, child was due for TDAP and MCV4. It wasn't until after these 2 vaccines were administered did mom provided a different vaccination record and asked for it to be updated. IT was then noted that TDAP and MCV had been given already. There was no adverse reaction while child was in the clinic. Mom was made aware child did not need the vaccines that were administered and asked that she always provide any records she may have to ensure accuracy. More
2855852 83 M FL 08/27/2025 PNC20
 PFIZER\WYETH
 LP4947
Extra dose administered Extra dose administered
Duplicate vaccine had received a Prevnar 20 on 8/17/2024 was not recorded in state Shots Duplicate vaccine had received a Prevnar 20 on 8/17/2024 was not recorded in state Shots
2855853 69 F 08/27/2025 FLU3
 SANOFI PASTEUR
 u8800ba
Injection site erythema, Injection site warmth, Oral herpes Injection site erythema, Injection site warmth, Oral herpes
pt experienced redness and skin that was warm to the touch below the left deltoid and extending down... pt experienced redness and skin that was warm to the touch below the left deltoid and extending down towards the elbow covering 2/3 of the arm. symptoms started approximately 12 hours after immunization and lasted for nearly 3 days. no treatments administered. pt stated the reaction resolved on its own and all symptoms have disappeared. she also reported the development of a fever blister on her upper lip that appeared on 8/22 that she believes may be connected. More
2855855 66 M FL 08/27/2025 RSV
 GLAXOSMITHKLINE BIOLOGICALS
 F4AC3
Chills, Extra dose administered, Fatigue, Influenza like illness, Myalgia Chills, Extra dose administered, Fatigue, Influenza like illness, Myalgia
Patient had already received this vaccine in October of 2023, and received the vaccine again in erro... Patient had already received this vaccine in October of 2023, and received the vaccine again in error on 8/25/25. Patient reported feeling okay on 8/27/25, but patient did report experiencing chills, muscle aches and fatigue (similar to flu-like symptoms) on 8/26/25. More
1262688 64 F VA 08/26/2025 COVID19
COVID19
 JANSSEN
JANSSEN

Unevaluable event; Impaired driving ability, Retinal artery occlusion, Thrombosi... Unevaluable event; Impaired driving ability, Retinal artery occlusion, Thrombosis, Vision blurred More
* Reported to H.D. Nurse on May 14 ? 12th 2021 * Reported to H.D. Nurse on May 14 ? 12th 2021
✓
2855540 IL 08/26/2025 MMR
 MERCK & CO. INC.
 Y008289
No adverse event, Product storage error No adverse event, Product storage error
No additional AE case reported; MMR II was inadvertently administered during a T/E; This spontaneous... No additional AE case reported; MMR II was inadvertently administered during a T/E; This spontaneous report was received from a medical assistant and refers to a patient of unknown age and gender. The patient's medical history was not reported. The patient's concurrent conditions were not reported. Concomitant therapies were not reported. On 26-Jul-2025, the patient was vaccinated with Measles, Mumps, and Rubella (Wistar RA 27-3) Virus Vaccine, Live (M-M-R II), 0.5 mL, lot #Y008289, expiration date: 24-Apr-2026, administered by unknown route as prophylaxis. The vaccine was reconstituted with sterile diluent (no administration details provided). The suspect vaccine was inadvertently administered during a temperature excursion: 9.69 C for 0 hours 15 minutes 0 seconds (Product storage error). No additional AE was reported. At the reporting time, the outcome of the event was unknown. The action taken with the suspect vaccine was not reported, but established as not applicable. This is one of three cases received from the same reporter. More
2855541 CA 08/26/2025 HPV9
 MERCK & CO. INC.
 Y012508
No adverse event, Product storage error No adverse event, Product storage error
No additional AE; Medical assistant calling to report administering doses of GARDASIL 9 after a temp... No additional AE; Medical assistant calling to report administering doses of GARDASIL 9 after a temperature excursion.; This spontaneous report was received from a medical assistant on 12-Aug-2025 and refers to a patient of unknown age and gender. The patient's medical history, concurrent conditions and concomitant therapies were not reported. On 11-AUG-2025, the patient was vaccinated with an improperly storage dose of) with Human Papillomavirus 9-valent Vaccine, Recombinant (GARDASIL 9), prefilled syringe (lot #Y012508, expiration date not reported, but upon internal validation established as 01-Jan-2027), frequency: total after temperature excursion for Prophylaxis (Product storage error). The administered dose of the vaccine experienced a temperature excursion 2.9 grade Fahrenheit for 5 minutes. No additional adverse event reported. This is one of several reports received from the same reporter (case # 2319351). More
2855542 F 08/26/2025 COVID19
 PFIZER\BIONTECH
COVID-19, Disease recurrence, Drug ineffective COVID-19, Disease recurrence, Drug ineffective
COVID 2x; COVID 2x; COVID 2x; This is a spontaneous report received from a Consumer or other non HCP... COVID 2x; COVID 2x; COVID 2x; This is a spontaneous report received from a Consumer or other non HCP. A 62-year-old female patient received BNT162b2 omicron (kp.2) (COMIRNATY (2024-2025 FORMULA)), as dose 1, single (Batch/Lot number: unknown) for covid-19 immunisation. The patient's relevant medical history included: "smoker" (ongoing), notes: long time. The patient's concomitant medications were not reported. The following information was reported: DRUG INEFFECTIVE (medically significant), COVID-19 (medically significant), DISEASE RECURRENCE (medically significant), outcome "unknown" and all described as "COVID 2x". Clinical course: The patient had COVID 2x but had only 1 shot. The reporter asked if it is possible to get 2nd, 3rd & booster shots. Also, the patient lives in a personal care home with a lot of disabled folks who always seem to be sick. The information on the batch/lot number for BNT162b2 omicron (kp.2) will be requested and submitted if and when received. More
2855543 08/26/2025 COVID19
 PFIZER\BIONTECH
COVID-19, Drug ineffective COVID-19, Drug ineffective
poor covid performance; poor covid performance; This is a spontaneous report received from a Consume... poor covid performance; poor covid performance; This is a spontaneous report received from a Consumer or other non HCP. A patient (age and gender not provided) received BNT162b2 omicron (kp.2) (COMIRNATY (2024-2025 FORMULA)), as dose 1, single (Batch/Lot number: unknown) for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. The following information was reported: DRUG INEFFECTIVE (medically significant), COVID-19 (medically significant), outcome "unknown" and all described as "poor covid performance". No follow-up attempts are possible. Batch/lot number is not provided, and it cannot be obtained. More
2855544 F CO 08/26/2025 COVID19
 PFIZER\BIONTECH
COVID-19, Drug ineffective COVID-19, Drug ineffective
I have COVID and I wanted to get Paxlovid but I can't afford it; I have COVID and I wanted to g... I have COVID and I wanted to get Paxlovid but I can't afford it; I have COVID and I wanted to get Paxlovid but I can't afford it; This is a spontaneous report received from a Consumer or other non HCP. A 72-year-old female patient received BNT162b2 omicron (kp.2) (COMIRNATY (2024-2025 FORMULA)), in Jun2025 as dose 1, single (Batch/Lot number: unknown) for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. The following information was reported: DRUG INEFFECTIVE (medically significant), COVID-19 (medically significant), outcome "unknown" and all described as "I have COVID and I wanted to get Paxlovid but I can't afford it". The information on the batch/lot number for BNT162b2 omicron (kp.2) will be requested and submitted if and when received. More
2855559 0.17 M NY 08/26/2025 RV5
 MERCK & CO. INC.
Blood lactic acid increased, Lactic acidosis, Leukocytosis, Pyrexia, White blood... Blood lactic acid increased, Lactic acidosis, Leukocytosis, Pyrexia, White blood cell count increased More
Fever, lactic acidosis Fever, lactic acidosis
2855572 08/26/2025 VARZOS
 UNKNOWN MANUFACTURER
 UNK
Urticaria Urticaria
broke out in hives; This non-serious case was reported by a consumer via interactive digital media a... broke out in hives; This non-serious case was reported by a consumer via interactive digital media and described the occurrence of hives in a patient who received Herpes zoster (Shingles vaccine) for prophylaxis. On an unknown date, the patient received the 1st dose of Shingles vaccine. On an unknown date, an unknown time after receiving Shingles vaccine, the patient experienced hives (Verbatim: broke out in hives). The outcome of the hives was not reported. It was unknown if the reporter considered the hives to be related to Shingles vaccine. It was unknown if the company considered the hives to be related to Shingles vaccine. Additional Information: GSK Receipt Date: 18-AUG-2025 This case was reported by a patient via interactive digital media. Patient had his/her first shingle shot and broke out in hives. Now patient was wondering if he/she should take the 2nd shot or not and asked how long he/she had before next shot. More
2855573 63 F TN 08/26/2025 FLU3
 SEQIRUS, INC.
Vomiting Vomiting
Caused vomiting for one day afterwards. Reporting for safety reasons. Caused vomiting for one day afterwards. Reporting for safety reasons.
2855574 12 M OH 08/26/2025 MENB
 NOVARTIS VACCINES AND DIAGNOSTICS
 47KS7
Wrong patient received product, Wrong product administered Wrong patient received product, Wrong product administered
Pt mistakenly got the wrong vaccine at today's visit. Instead of the HPV that was ordered for h... Pt mistakenly got the wrong vaccine at today's visit. Instead of the HPV that was ordered for him, he received the Bexsero that was intended for his sibling who was also present for his well check and in the room with him. This mistake was noted immediately and the family and pt were told of the incident. I have been in contact w mom and gave her the info and the data that is noted below. She will watch him for any side effects and we will continue to be in contact. We opted to hold off on the HPV until next visit. Info/data as below: Bexsero (meningococcal group B vaccine) has been studied in 12-year-old children. Clinical trials and post-licensure studies have included adolescents aged 10-25 years, which encompasses 12-year-olds, and have demonstrated immunogenicity and safety in this age group. The agency specifically recommended Bexsero for persons aged 10 years and older who are at increased risk for serogroup B meningococcal disease, and immunogenicity and safety data for this age range are presented in their guidelines. Randomized controlled trials and meta-analyses have evaluated immunogenicity and safety in children and adolescents under 18 years, including those aged 12, showing robust immune responses and an acceptable safety profile after the recommended two-dose series for adolescents. The vaccine is licensed for use in this age group in multiple countries, and real-world experience confirms finding from pre-licensure studies. The safety profile remains consistent across different populations and dosing schedules, with no evidence of increased risk in 12-year-olds compared to older adolescents. Continued pharmacovigilance supports the conclusion that Bexsero is generally safe and well tolerated in adolescents, with adverse events predominantly mild and transient. VAERS report done and will cont to communicate w family to follow for any SE. Pt. with no noted or experienced adverse side effects after the dose. Just received the dose accidentally and at age 12 yo. More
2855575 17 VA 08/26/2025 MEN
 UNKNOWN MANUFACTURER
Feeling abnormal, Pharyngitis, Streptococcus test negative Feeling abnormal, Pharyngitis, Streptococcus test negative
Illness (pharyngitis) starting 15Aug25 Illness (pharyngitis) starting 15Aug25
2855576 76 F AK 08/26/2025 COVID19
COVID19
COVID19
COVID19
 PFIZER\BIONTECH
PFIZER\BIONTECH
PFIZER\BIONTECH
PFIZER\BIONTECH
 MD3414
MD3414
MD3414
MD3414
Blood pressure increased, Bradycardia, Brain natriuretic peptide, C-reactive pro... Blood pressure increased, Bradycardia, Brain natriuretic peptide, C-reactive protein, Cardiac monitoring abnormal; Cardiac stress test normal, Chills, Dyspnoea, Echocardiogram normal, Fatigue; Nausea, Palpitations, Positron emission tomogram, Positron emission tomogram normal, Pulse abnormal; Red blood cell sedimentation rate, Troponin, Ventricular extrasystoles, Ventricular tachycardia More
chills that evening; woke up next AM with EXTREME fatigue & SOB; vitals - Bradycardia (pulse @ 4... chills that evening; woke up next AM with EXTREME fatigue & SOB; vitals - Bradycardia (pulse @ 40-50 / normally around 100), and elevated blood pressure. (am former RN; own high quality monitoring equipment). Chose not to go to Emerg Rm; couldn't get appt to see own cardiologist. Monitored self for weeks - with abnormal pulse & hypertensive B/P inconsistent, yet persisting; more infrequent as weeks elapsed. Finally saw cardiac NP. Put on Holter monitor; result - nonsustained tachycardia with increased PVC's. Cardiologist ordered labwork, cardiac US, result: increased pulmonary hypertension; Pet CT/Stress Test, result: normal. Rx prescribed: metoprolol. Cardiac MRI to be scheduled. status currently being evaluated. Initial symptoms of reaction to vaccine also included occasional nausea and heart palpitations. This was my 10th COVID vaccine; chose to get it because of CDC recommendations. Symptoms that still persist are fatigue and shortness of breath, but they have improved. More
2855606 F PR 08/26/2025 VARZOS
VARZOS
 UNKNOWN MANUFACTURER
UNKNOWN MANUFACTURER
 UNK
UNK
Chills, Fatigue, Headache, Injection site erythema, Injection site pain; Injecti... Chills, Fatigue, Headache, Injection site erythema, Injection site pain; Injection site swelling More
Pain, redness, and swelling at the injection site; Pain, redness, and swelling at the injection site... Pain, redness, and swelling at the injection site; Pain, redness, and swelling at the injection site Muscle pain Tiredness Headache Shivering; Pain, redness, and swelling at the injection site Muscle pain Tiredness Headache Shivering; Muscle pain; 29-JUL-2025 00:00Pain, redness, and swelling at the injection site Muscle pain Tiredness Headache Shivering; Headache; Shivering; This non-serious case was reported by a consumer via call center representative and described the occurrence of injection site pain in a 58-year-old female patient who received Herpes zoster (Shingles vaccine) for prophylaxis. Concomitant products included tirzepatide (Mounjaro). On 29-JUL-2025, the patient received Shingles vaccine. On 29-JUL-2025, less than a day after receiving Shingles vaccine, the patient experienced injection site pain (Verbatim: Pain, redness, and swelling at the injection site), injection site erythema (Verbatim: Pain, redness, and swelling at the injection site Muscle pain Tiredness Headache Shivering), injection site swelling (Verbatim: Pain, redness, and swelling at the injection site Muscle pain Tiredness Headache Shivering), muscle pain (Verbatim: Muscle pain), tiredness (Verbatim: 29-JUL-2025 00:00Pain, redness, and swelling at the injection site Muscle pain Tiredness Headache Shivering), headache (Verbatim: Headache) and shivering (Verbatim: Shivering). The outcome of the injection site pain, injection site erythema, injection site swelling, muscle pain, tiredness, headache and shivering were not resolved. It was unknown if the reporter considered the injection site pain, injection site erythema, injection site swelling, muscle pain, tiredness, headache and shivering to be related to Shingles vaccine. It was unknown if the company considered the injection site pain, injection site erythema, injection site swelling, muscle pain, tiredness, headache and shivering to be related to Shingles vaccine. Additional Information: GSK Receipt Date: 30-JUL-2025 The patient had pain, redness, and swelling at the injection site, muscle pain, tiredness, headache and shivering from 29 Jul 2025. More
2855609 F KY 08/26/2025 PNC15
PNC15
UNK
UNK
 MERCK & CO. INC.
MERCK & CO. INC.
UNKNOWN MANUFACTURER
UNKNOWN MANUFACTURER
 Y010032
Y010032
Bed sharing, Death, Decreased appetite, Infant irritability, Pyrexia; Unresponsi... Bed sharing, Death, Decreased appetite, Infant irritability, Pyrexia; Unresponsive to stimuli; Bed sharing, Death, Decreased appetite, Infant irritability, Pyrexia; Unresponsive to stimuli More
DEATH; INFANT IRRITABILITY; UNRESPONSIVE TO STIMULI; DECREASED APPETITE; PYREXIA; Information has be... DEATH; INFANT IRRITABILITY; UNRESPONSIVE TO STIMULI; DECREASED APPETITE; PYREXIA; Information has been received from Food And Drug Administration Agency (FDA) via Vaccine Adverse Events Reporting System (VAERS) (Agency #2839201-1) on 17-JUL-2025. This spontaneous report and refers to an infant (age reported as 0.75-year-old) female patient. The patient's medical history, concurrent conditions and concomitant therapies were not reported. On 09-APR-2025, the patient was vaccinated with the third dose of pneumococcal 15-valent conjugate vaccine (VAXNEUVANCE) suspension for injection, administered intramuscularly in left leg, lot #Y010032, expiration date was not reported, however upon internal validation determined as 17-FEB-2027, for prophylaxis (exact dose was not reported); on the same day, she was vaccinated with 3rd dose of diphtheria vaccine toxoid (+) HIB vaccine conj (tet tox) (+) pertussis vaccine acellular 5-component (+) polio vaccine inact 3v (MRC 5) (+) tetanus vaccine toxoid) (PENTACEL), administered intramuscularly in right leg, lot #UK196AA, for prophylaxis (exact dose and expiration date were not reported). On 09-APR-2025, in the evening, the child had fever and fussiness; fever resolved on 10-APR-2025 (discrepancy, outcome reported as fatal), however, her fussiness persisted, and child's appetite was poor. Given child's fussiness the evening of 10-APR-2025, her mother reported that the child slept in her parent's bed. Her parents awakened to find her non-responsive on the morning of 11-APR-2025 and they activated Emergency Medical Services (EMS). Child was transported to hospital. She did not survive and was pronounced dead in the hospital (conflicting information, the onset date of the events of infant irritability, decreased appetite, pyrexia, unresponsive to stimuli, and death was reported as 11-APR-2025; she was treated at emergency room and hospitalized due to the events; she was also treated at emergency room/department or urgent care). The patient died because of the events of infant irritability, unresponsive to stimuli, decreased appetite, and pyrexia. It was unknown whether an autopsy was performed. Causality assessment was not provided. Follow up information has been received on 21-AUG-2025. Investigation summary for VAXNEUVANCE, Batch/Lot #Y010032: Reviews performed as a result of this adverse event concluded that no unexpected events arose during the manufacture of V114 0.5ML 1DOSE SYR Batch number 0001759288 material number 2016658 at MSD Carlow which could have impacted on product quality. No deviations were deemed to have an impact on the batch prior to batch disposition. All acceptance criteria were met. All components utilized in the batch underwent QC inspection and release as per applicable quality standards and site procedures prior to use in the batch. Sterility, Bioburden and endotoxin testing were performed as per approved site procedures and results met specification. Release testing conformed to all specifications. A supporting investigation was requested from the drug substance (DS) manufacturing site MSD (Inv-012951). The investigation did not highlight any issues which would compromise the quality, safety, potency or efficacy of any of the Drug Substance batches consumed in Drug product batch 0001759288. The investigation concluded that the Drug Substance batches conform to all release specifications. A supporting investigation was also completed by the MSD packaging site (Inv-012952). Based on their investigation, no systemic packaging inadequacy of package batch Y010032 were identified at the Merck manufacturing facility that could impact the quality attributes of the product. Based on this investigation of the adverse event, no systemic manufacturing inadequacy was identified at the MSD manufacturing facility that could impact the quality attributes of the product. There have been no additional requests for information or additional testing relating to this Adverse Event.; Reported Cause(s) of Death: DECREASED APPETITE; INFANT IRRITABILITY; PYREXIA; UNRESPONSIVE TO STIMULI More
✓ ✓
2855610 14 M OH 08/26/2025 HPV9
HPV9
HPV9
HPV9
 MERCK & CO. INC.
MERCK & CO. INC.
MERCK & CO. INC.
MERCK & CO. INC.
 Z004534
Z004534
Z004534
Z004534
Blood thyroid stimulating hormone normal, Brain fog, C-reactive protein normal, ... Blood thyroid stimulating hormone normal, Brain fog, C-reactive protein normal, Differential white blood cell count normal, Eye pain; Feeling abnormal, Feeling hot, Full blood count normal, General physical condition abnormal, Glycosylated haemoglobin; Headache, Mental impairment, Metabolic function test normal, Red blood cell sedimentation rate normal, Respiratory pathogen panel; Thyroxine free abnormal More
Pt reports that 1-2 days after his HPV vaccine on 8/4 he developed some headaches frontal location a... Pt reports that 1-2 days after his HPV vaccine on 8/4 he developed some headaches frontal location and a sensation of feeling hot inside without a fever or feeling hot to touch and felt unable to cool down. Pt appeared "blah" or fatigued like getting sick to mom but without other symptoms. The most concerning was his complaint of mental fog and inability to think especially worsened by activity. Pt also described feeling disconnected. Symptoms persisted 9 days when presented for evaluation. At that time had also developed left eye pain. Ordered labs to r/o any other cause for symptoms, none found. Mother stated that, as of today symptoms are improving, he is still having headaches. More
2855611 1.92 F MI 08/26/2025 DTAP
HEPA
 GLAXOSMITHKLINE BIOLOGICALS
GLAXOSMITHKLINE BIOLOGICALS
 JF7DM
L4EA4
Injection site cellulitis, Injection site erythema, Injection site pain, Injecti... Injection site cellulitis, Injection site erythema, Injection site pain, Injection site swelling; Injection site cellulitis, Injection site erythema, Injection site pain, Injection site swelling More
Parent called back to clinic on 08/25/25 to inform staff injection site of Dtap was very red, swolle... Parent called back to clinic on 08/25/25 to inform staff injection site of Dtap was very red, swollen, and hurting. Mom reported to nursing staff right thigh swelling " as big as my hand" . Advised patient's parent that day to have patient evaluated that day and to report to Urgent care for assessment. Mom called back later and stated leg was twice the size of normal reddish purple discoloration on back side of right leg near knee. Parent again advised needed to take patient to urgent care for immediate assessment. Parent called back later in the evening stating took patient to urgent care and was prescribed an antibiotic for cellulitis. Per Urgent care note patient prescribed Keflex 125mg/5mL every 8 hours x 7 days. Advised to f/u with PCP in 1 week for recheck. More
2855612 19 F 08/26/2025 MENB
 PFIZER\WYETH
 LW8910
Pain in extremity, Rash macular, Skin warm Pain in extremity, Rash macular, Skin warm
Patient received Trumenba vaccine during 8/20/25 visit. Patient sent in a provider a message with a ... Patient received Trumenba vaccine during 8/20/25 visit. Patient sent in a provider a message with a picture showing a large red blotchy area on the patients arm. Patient states that her arm is sore and warm. RN showed message to a provider. Provider recommends patient been seen in clinic. Patient has been informed of recommendation to be seen. Provider has concerns for possible cellulitis. More
2855613 0.33 M UT 08/26/2025 DTPPVHBHPB
 MSP VACCINE COMPANY
 U7776AA
Refusal of vaccination Refusal of vaccination
Pt mom did not want this full vaccine. It was given by mistake. Pt mom did not want this full vaccine. It was given by mistake.
2855614 3 M NE 08/26/2025 HEPA
 MERCK & CO. INC.
 Y009094
Incorrect dose administered, No adverse event Incorrect dose administered, No adverse event
Patient was given 1ml instead of the pediatric dose of 0.5ml. Called and spoke with his mom and she... Patient was given 1ml instead of the pediatric dose of 0.5ml. Called and spoke with his mom and she stated no adverse effects from the vaccine. More
2855615 60 F SC 08/26/2025 PNC20
 PFIZER\WYETH
Injection site cellulitis Injection site cellulitis
develop cellulitis about 1 inch below the injection site develop cellulitis about 1 inch below the injection site
2855616 50 F OR 08/26/2025 TDAP
 GLAXOSMITHKLINE BIOLOGICALS
 37R35
Pyrexia, Rash Pyrexia, Rash
Fever of 101 for two days and rash appeared-starting on their face and head, now moving down their b... Fever of 101 for two days and rash appeared-starting on their face and head, now moving down their body. More
2855617 15 M TX 08/26/2025 MMRV
 MERCK & CO. INC.
 Z010383
No adverse event, Product administered to patient of inappropriate age No adverse event, Product administered to patient of inappropriate age
No adverse reaction reported as of 8/26/2025 10:15am. No adverse reaction reported as of 8/26/2025 10:15am.
2855618 0.33 M MI 08/26/2025 DTAPHEPBIP
 GLAXOSMITHKLINE BIOLOGICALS
 9C295
Injection site nodule Injection site nodule
PATIENT RECEIVED A 1 IN X 1 IN NODULE AT THE SITE OF INJECTION. PATIENT RECEIVED A 1 IN X 1 IN NODULE AT THE SITE OF INJECTION.
2855619 65 M WI 08/26/2025 VARZOS
 GLAXOSMITHKLINE BIOLOGICALS
 j32pb
Death Death
Unknown. Report is made after review of medical record by medical examiner. Unknown if recent vaccin... Unknown. Report is made after review of medical record by medical examiner. Unknown if recent vaccination had any effect of cause of death which is reported as Atherosclerotic and Hypertensive Cardiovascular Disease with Other significant conditions: diabetes mellitus, hypothyroidism, smoking, and chronic ethanol use. No autopsy was performed. More
✓
2855620 17 F MA 08/26/2025 MNQ
 SANOFI PASTEUR
 U8562AA
Extra dose administered, No adverse event Extra dose administered, No adverse event
Patient was scheduled to receive dose # 2 of Meningitis B Vaccine (Bexsero) but was given a third do... Patient was scheduled to receive dose # 2 of Meningitis B Vaccine (Bexsero) but was given a third dose of Menquadfi accidentally. Pt with no side effects. More
2855621 0.17 M OH 08/26/2025 PNC15
 MERCK & CO. INC.
 Y005465
Hyporesponsive to stimuli, Pyrexia Hyporesponsive to stimuli, Pyrexia
Pt got a Prevnar vaccine yesterday and got a low grade temp. Around 10 pm temp went to 101.5 and he ... Pt got a Prevnar vaccine yesterday and got a low grade temp. Around 10 pm temp went to 101.5 and he was fussy and they went to the ER. At the ER it was 101.3 and gave him Tylenol and said to call our office. This morning temp was 102 at 9:30am-10am and mom gave him Tylenol which brought it down to 99.6. More
2855622 6 M 08/26/2025 DTAPIPV
MMRV
 GLAXOSMITHKLINE BIOLOGICALS
MERCK & CO. INC.
 Y49BZ
Z009665
Product administered to patient of inappropriate age; Product administered to pa... Product administered to patient of inappropriate age; Product administered to patient of inappropriate age More
Given at wrong age. Given at wrong age.
2855623 16 M TX 08/26/2025 MNQ
 SANOFI PASTEUR
 u8562aa
Syncope Syncope
Patient fainted shortly after vaccine administration Patient fainted shortly after vaccine administration
2855624 2 M AZ 08/26/2025 PNC20
 PFIZER\WYETH
 LJ5282
Erythema, Pyrexia, Skin warm, Swelling Erythema, Pyrexia, Skin warm, Swelling
WARM TO THE TOUCH, RED, SWELLING, FEVER. MOM WAS GIVING HIM TYLENOL WARM TO THE TOUCH, RED, SWELLING, FEVER. MOM WAS GIVING HIM TYLENOL
2855625 69 F CO 08/26/2025 VARZOS
 GLAXOSMITHKLINE BIOLOGICALS
 nr4t5
Dizziness, Influenza like illness Dizziness, Influenza like illness
pt had severe flu like symptoms and felt like fainting pt had severe flu like symptoms and felt like fainting
2855626 59 M NC 08/26/2025 VARZOS
VARZOS
 GLAXOSMITHKLINE BIOLOGICALS
GLAXOSMITHKLINE BIOLOGICALS
 FT95N
FT95N
Chest X-ray normal, Chills, Headache, Hyperhidrosis, Malaise; Pain, Productive c... Chest X-ray normal, Chills, Headache, Hyperhidrosis, Malaise; Pain, Productive cough, Pyrexia, Respiratory pathogen panel, SARS-CoV-2 test negative More
After immunization has been with fever, chills, diaphoresis, headaches, body aches/malaise, producti... After immunization has been with fever, chills, diaphoresis, headaches, body aches/malaise, productive cough. More
2855627 64 F IA 08/26/2025 VARZOS
 GLAXOSMITHKLINE BIOLOGICALS
 GJ952
Injection site erythema, Injection site pruritus, Injection site swelling, Injec... Injection site erythema, Injection site pruritus, Injection site swelling, Injection site warmth More
GOT RED, HOT, ITCHY BAND (RASH) AROUND HER ARM. 4 INCHES WIDE AND 2 INCHES BELOW INJECTION SITE. STA... GOT RED, HOT, ITCHY BAND (RASH) AROUND HER ARM. 4 INCHES WIDE AND 2 INCHES BELOW INJECTION SITE. STARTED 6 DAYS AFTER INJECTION. IT WAS LOCATED BELOW THE INJECTION SITE WHERE HER FREESYTLE LIBRE WAS. SHE REPORTED HAVING SOME SWELLING AT THE INJECTION SITE FOR A DAY/TWO AFTER THE INJECTION THAT HAS NOW DISSIPATED. More
2855628 0.58 M CA 08/26/2025 DTAPIPV
 SANOFI PASTEUR
 U8383AB
No adverse event, Wrong product administered No adverse event, Wrong product administered
I gave patient DTap-IPV when I was supposed to give patient Vaxelis. No symptoms, patient waiting in... I gave patient DTap-IPV when I was supposed to give patient Vaxelis. No symptoms, patient waiting in the room for 15 minutes and there was no reaction to the vaccine. More
2855629 53 M CA 08/26/2025 FLU3
 SANOFI PASTEUR
 u8800ca
No adverse event, Product administered to patient of inappropriate age No adverse event, Product administered to patient of inappropriate age
NO ADVERSE REACTION NOTED. PATIENT REQUESTED THE HIGH DOSE FLU VACCINE. NO ADVERSE REACTION NOTED. PATIENT REQUESTED THE HIGH DOSE FLU VACCINE.
2855630 4 F CA 08/26/2025 DTAPIPV
 GLAXOSMITHKLINE BIOLOGICALS
 5C79N
Incorrect route of product administration, No adverse event Incorrect route of product administration, No adverse event
no symptoms,no signs, vaccine was placed subcutaneous route instead of intramuscular no symptoms,no signs, vaccine was placed subcutaneous route instead of intramuscular
2855631 12 M MT 08/26/2025 TDAP
TDAP
 GLAXOSMITHKLINE BIOLOGICALS
GLAXOSMITHKLINE BIOLOGICALS

Dizziness, Gait disturbance, Heart rate increased, Malaise, Pallor; Tinnitus, Vi... Dizziness, Gait disturbance, Heart rate increased, Malaise, Pallor; Tinnitus, Visual impairment More
About 5 minutes after vaccination. White complexion, dizzy, seeing spots and colors, ears ringing, r... About 5 minutes after vaccination. White complexion, dizzy, seeing spots and colors, ears ringing, rapid heartbeat, not feeling well, trouble walking. We sat him down and the pharmacist had us call EMS just to be safe. EMTs came and checked his vitals. After about 20 minutes he started feeling better and we went home and he just relaxed. More
2855632 08/26/2025 COVID19
DTPIHI
PNC20
RV5
RVX
 MODERNA
UNKNOWN MANUFACTURER
PFIZER\WYETH
MERCK & CO. INC.
UNKNOWN MANUFACTURER




Body temperature, Irritability, Pyrexia, Somnolence; Body temperature, Irritabil... Body temperature, Irritability, Pyrexia, Somnolence; Body temperature, Irritability, Pyrexia, Somnolence; Body temperature, Irritability, Pyrexia, Somnolence; Body temperature, Irritability, Pyrexia, Somnolence; Body temperature, Irritability, Pyrexia, Somnolence More
sleepy; irritable/ cranky; fever; This spontaneous report was received from a Consumer or other non ... sleepy; irritable/ cranky; fever; This spontaneous report was received from a Consumer or other non health professional and refers to a patient of unknown age and gender. The patient's concurrent conditions and concomitant therapies were not reported. The patient previously had fever and irritability with other symptoms with vaccines at 2 months, 4 months (same as other vaccines received on 11 Jul-2025). On 11-Jul-2025, the was vaccinated with a dose of Rotavirus Vaccine, Live, Oral, Pentavalent (ROTATEQ), 1 dosage form administered by oral route (exact dose, lot # and expiration date were not reported) for prophylaxis (indication reported as unknown but by default changed to prophylaxis). On the same day, the patient started therapy with clesrovimab (ENFLONSIA) (reported as RSV vaccine) prefilled syringe, 1 dosage form administered by unknown route for unknown indication (exact dose, lot # and expiration date were not reported). On the same day, he was vaccinated with a dose of COVID-19 vaccine mRNA omicron (KP.2) Moderna (MODERNA COVID-19 VACCINE) dose 1 administered intramuscularly (lot # and expiration date were not reported) for COVID-19; with a dose of Pneumococcal vaccine conj 20v (CRM197) 1 dosage form administered by unknown route for unknown indication (expiration date, and lot # were not reported); and with a dose of Diphtheria vaccine (+) Hepatitis b vaccine (+) HIB vaccine (+) Pertussis vaccine (+) Polio vaccine (+) Tetanus vaccine 1 dosage form administered by unknown route for unknown indication (indication, expiration date, and lot # were not reported). It was reported that the patient received first dose of Moderna Covid vaccine at 6-month checkup along with RSV, rotavirus, and other standard vaccines. The patient received the vaccine at noon. On 11-Jul-2025, the patient experienced somnolence (sleepy). On the same day at 5:00 PM, the patient experienced irritability (irritable/ cranky) and pyrexia (fever). On that day at 5:00 PM, body temperature was 101 F. It was also reported that, post vaccination, the patient developed fever and he was sleepy with irritable symptom which started about two hours after vaccination. He was feverish and cranky until mid-day on 13-Jul-2025. The fever never reached over 101 F. From 11-Jul-2025 to 13-Jul-2025, the patient was treated with paracetamol (TYLENOL) (oral use) at a dose of 2.5 milliliter every four hours. Paracetamol (TYLENOL) significantly improved the symptoms. The patient did not experience any additional symptoms or events. On 12-Jul-2025, somnolence had resolved. On 13-Jul-2025, irritability and pyrexia had resolved. The action taken with COVID-19 vaccine mRNA omicron (KP.2) Moderna (MODERNA COVID-19 VACCINE) was unknown (by default changed to not applicable). The action taken with clesrovimab (ENFLONSIA) was not reported. The action taken with Diphtheria vaccine (+) Hepatitis b vaccine (+) HIB vaccine (+) Pertussis vaccine (+) Polio vaccine (+) Tetanus vaccine, Pneumococcal vaccine conj 20v (CRM197) and Rotavirus Vaccine, Live, Oral, Pentavalent (ROTATEQ) was not applicable. The causal relationship between the reported adverse events and the suspect therapies was not reported.; Sender's Comments: Priority : 4 , Is case serious : No , Index user : , Index date : 2025-07-28 , MNSC number : , CLIC number : , ESTAR number : , IRMS number : MOD-2025-788098 , Central date : 2025-07-28 , Classification : DMC, Attachment description : Post Marketing Basic , Safety case number : More
📋 Privacy Policy & Data Disclaimer